A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)-Reference-Cited by-同舟云学术

A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

Published:2019-01-10 Issue:1 Volume:20 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Mikhail Ashraf I.^ORCID,Schön Staffan,Simon Sylvia,Brown Christopher,Hegbrant Jörgen B. A.,Jensen Gert,Moore Jason,Lundberg Lennart D. I.

Funder

Pharmacosmos A/S

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-018-1159-z.pdf

Reference34 articles.

1. Kidney Disease Improving Global Outcomes. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279–335.

2. National Institute for Health and Care Excellence (NICE). Chronic kidney disease: managing anaemia. 2015 NICE guideline. https://www.nice.org.uk/guidance/ng8 . Accessed 7 Sep 2018.

3. Tsukamoto T, Matsubara T, Akashi Y, Kondo M, Yanagita M. Annual iron loss associated with hemodialysis. Am J Nephrol. 2016;43:32–8.

4. Rostoker G, Vaziri ND, Fishbane S. Iatrogenic iron overload in dialysis patients at the beginning of the 21st century. Drugs. 2016;76:741–57.

5. Biggar P, Leistikow F, Walper A. A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemia. Clin Nephrol. 2016;86:310–8.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2023

2. A brief overview on current status of nanomedicines for treatment of pancytopenia: Focusing on chemotherapeutic regime;Journal of Drug Delivery Science and Technology;2021-02

3. An evaluation of ferric derisomaltose as a treatment for anemia;Expert Review of Hematology;2020-12-14

4. Cost-minimization analysis between intravenous iron sucrose and iron sucrose similar in hemodialysis patients;Expert Review of Pharmacoeconomics & Outcomes Research;2019-07-01

5. Iron isomaltoside 1000;Reactions Weekly;2019-03